Showing 35,658 results

Filters

THT wants votes for Labour's policy-making website by Friday 13th October

News
11 October 2006
Hepatitis & HIV

Lab markers can predict advanced liver fibrosis in more than 90% of cases in HIV/HCV coinfected

News
10 October 2006
Starting treatment

Two-drug maintenance with tenofovir-efavirenz less effective than triple therapy

News
10 October 2006

HIV Weekly - October 10th 2006

October 2006

Hepatitis C infection limits cholesterol increases caused by antiretrovirals

News
9 October 2006
People with limited treatment options

Darunavir response did not differ by prior PI in POWER studies

News
9 October 2006
Starting treatment

Immunologically discordant response to HIV therapy associated with increased risk of disease progression

News
6 October 2006

Needle-free administration of enfuvirtide reduces injection site reactions

News
6 October 2006
Side effects

Reduced dose of Kaletra soft-gel capsule effective in small study (corrected)

News
6 October 2006

Kaletra, saquinavir have anti-malarial effects in test tube

News
5 October 2006

Community-acquired MRSA soars among people with HIV in San Francisco

News
5 October 2006

Anti-HIV therapy suppresses viral load well in older patients, but CD4 cell recovery may be impaired

News
3 October 2006
Transmission & prevention

EU survey finds widespread ignorance of HIV transmission risks

News
3 October 2006
Hepatitis & HIV

Higher baseline HCV viral load and CD4 percentage predict response to hepatitis C treatment in HIV/HCV co-infected patients

News
3 October 2006

HIV Weekly - October 3rd 2006

October 2006
New & experimental HIV treatments

Darunavir: negative interactions with Kaletra, Viagra and contraceptive pill reported

News
2 October 2006
Testing & health monitoring

CXCR4, dual or mixed tropic HIV does not reduce response to HAART

News
2 October 2006
Side effects

Atazanavir/efavirenz NRTI-sparing regimen effective, but raises lipid levels

News
1 October 2006
Starting treatment

Boosted fosamprenavir and atazanavir show comparable potency, tolerability in treatment-naive

News
30 September 2006
People with limited treatment options

MK-0518: three-quarters of highly treated patients have undetectable viral load at 24 weeks

News
30 September 2006
New & experimental HIV treatments

Antibody to CCR5 receptor safe, effective, suitable for weekly dosing, preliminary study shows

News
30 September 2006
New & experimental HIV treatments

Novel NRTI elvucitabine active against HIV in a 7-day monotherapy study

News
30 September 2006
Starting treatment

Trizivir non-inferior to unboosted atazanavir in treatment-naive

News
29 September 2006
Starting treatment

16% of drug-naive entering GSK US studies already have resistance

News
29 September 2006